02 June 2026 : Clinical Research
Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial
Zhong Zhang ABC 1, Zhixu Wang BC 1, Wanwan Gong DEF 1, Wei Jiang AF 1*, Longjiao Zheng DEF 1, Zhiyang Yu AEF 1DOI: 10.12659/MSM.952468
Med Sci Monit 2026; 32:e952468
Figure 2 SBP (A), DBP (B), MAP (C), and HR (D) recorded at 5 time points during the study. T1: before intravenous administration of esketamine or remifentanil (baseline); T2: 1 minute after intravenous injection of ciprofol; T3: cervical dilation; T4: at the end of the operation; T5: upon discharge from the PACU. * P<0.05, group CK vs group CR. CK – ciprofol-esketamine regimen; CR – ciprofol-remifentanil regimen; DBP – diastolic blood pressure; HR – heart rate; MAP – mean arterial pressure; PACU – post-anesthesia care unit; SBP – systolic blood pressure.